000 02224nam a2200433 i 4500
001 ocn960810608
003 OCoLC
005 20161111130803.0
007 he bmb024bbca
008 161017s2016 dcu bb f000 0 eng c
040 _aGPO
_beng
_erda
_cGPO
042 _apcc
043 _an-us---
050 1 4 _aKF27
_b.E553 2014z
074 _a1019-B-01 (MF)
086 0 _aY 4.C 73/8:113-171
088 _aSerial no. 113-171 (United States. Congress. House. Committee on Energy and Commerce)
099 _aY 4.C 73/8:113-171
110 1 _aUnited States.
_bCongress.
_bHouse.
_bCommittee on Energy and Commerce.
_bSubcommittee on Health,
_eauthor.
240 1 0 _a21st century cures (2014 September 9)
245 1 0 _a21st century cures :
_bexamining the regulation of laboratory-developed tests : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, September 9, 2014.
246 3 _aTwenty-first century cures
264 1 _aWashington :
_bU.S. Government Publishing Office,
_c2016.
300 _av, 178 pages ;
_c24 cm
336 _atext
_btxt
_2rdacontent
337 _amicroform
_bh
_2rdamedia
338 _amicrofiche
_bhe
_2rdacarrier
500 _aShipping list no.: 2016-0177-M.
500 _aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
504 _aIncludes bibliographical references.
500 _a"Serial No. 113-171."
500 _aCRDP Project record.
533 _aMicrofiche.
_b[Washington, D.C.] :
_cU.S. Government Printing Office,
_d[2016]
_e2 microfiches : negative.
650 0 _aDiagnosis, Laboratory
_xSafety regulations
_zUnited States.
650 0 _aClinical chemistry
_xSafety regulations
_zUnited States.
655 7 _aLegislative hearings.
_2lcgft
776 0 8 _iPrint version:
_aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
_s21st century cures (2014 September 9)
_w(DLC) 2015464828
_w(OCoLC)946536716
776 0 8 _iOnline version:
_aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
_s21st century cures (2014 September 9)
_w(OCoLC)945978675
999 _c255736
_d255736